{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:12:16Z","timestamp":1793304736609,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>M\u00fcller cell pyroptosis and immune inflammation-induced retinal ganglion cell (RGC) damage are the core pathological markers and potential therapeutic targets for neurodegeneration in early diabetic retinopathy (DR). Qiming Granules (QMG)\u2014recommended by the traditional Chinese medicine guidelines for DR owing to their multi-target immunomodulatory, antioxidant, and microvascular protective effects. This study aimed to clarify the protective effect of QMG on early DR neurodegeneration, reveal their neuroprotective mechanism by regulating the P2X7R\/NLRP3 pathway to inhibit M\u00fcller cell pyroptosis and immune inflammation, identify the chemical components of QMG and its absorbed components in rat plasma, study the effects of major absorbed components on inhibiting M\u00fcller cells pyroptosis and immune inflammatory response, and investigate the potential pharmacodynamic substances of QMG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An in vivo DR neurodegeneration model was established. HE staining, transmission electron microscopy, WB, and ELISA were used for detecting RGC apoptosis, histomorphological changes, P2X7R\/NLRP3 expression, and pyroptosis pathway proteins. An in vitro high-glucose-induced M\u00fcller cell pyroptosis model was constructed. After activating or inhibiting P2X7R, lactate dehydrogenase levels were measured; moreover, ELISA, WB, and immunofluorescence were performed to examine cell membrane damage, inflammatory factor release, and pyroptosis pathway protein expression. UPLC-Q-Orbitrap HRMS was utilized to characterize the chemical and blood-entering profiles of QMG, aiming to evaluate the inhibitory effects of its main blood components on high glucose-induced M\u00fcller cell pyroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>QG inhibited RGC apoptosis, the P2X7R\/NLRP3 pathway, and retinal cell pyroptosis in DR neurodegeneration model rats. In vitro, QMG reduced membrane rupture and pyroptosis pathway protein expression in M\u00fcller cells by suppressing the P2X7R\/NLRP3 pathway, ultimately inhibiting M\u00fcller cell pyroptosis and immune-inflammatory responses. Nine of the 70 compounds identified in QMG were absorbed into the bloodstream. The main absorbed components, astragaloside IV and puerarin, effectively mitigated high glucose-induced M\u00fcller cell pyroptosis, with astragaloside IV exhibiting a more pronounced effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>QMG mitigated M\u00fcller cell pyroptosis and inflammatory responses by regulating the P2X7R\/NLRP3 pathway, thereby inhibiting early neurodegeneration in DR. Astragaloside IV and puerarin absorbed into systemic circulation, significantly attenuated high glucose-induced pyroptosis, and suppressed immunoinflammatory responses in M\u00fcller cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01370-8","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:47:16Z","timestamp":1773658036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Qiming granules regulate M\u00fcller cell pyroptosis and the P2X7R\/NLRP3 immune inflammatory pathway in diabetic retinopathy"],"prefix":"10.1186","volume":"21","author":[{"given":"Qi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"16","key":"1370_CR1","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1007\/s00018-021-03893-9","volume":"78","author":"L Ji","year":"2021","unstructured":"Ji L, Tian H, Webster KA, et al. Neurovascular regulation in diabetic retinopathy and emerging therapies. Cell Mol Life Sci. 2021;78(16):5977\u201385.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"1370_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","volume":"17","author":"DA Antonetti","year":"2021","unstructured":"Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17(4):195\u2013206.","journal-title":"Nat Rev Endocrinol"},{"key":"1370_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100940","volume":"84","author":"WW Pan","year":"2021","unstructured":"Pan WW, Lin F, Fort PE. The innate immune system in diabetic retinopathy. Prog Retin Eye Res. 2021;84:100940.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"1370_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-0886-z","volume":"18","author":"X Ding","year":"2018","unstructured":"Ding X, Gu R, Zhang M, et al. Microglia enhanced the angiogenesis, migration and proliferation of co-cultured RMECs. BMC Ophthalmol. 2018;18(1):249.","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"1370_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1370_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/imr.12287","volume":"265","author":"I Jorgensen","year":"2015","unstructured":"Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev. 2015;265(1):130\u201342.","journal-title":"Immunol Rev"},{"key":"1370_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.758375","volume":"12","author":"DJ Lee","year":"2021","unstructured":"Lee DJ, Xu H, Taylor AW. Editorial: Retinal immunobiology and retinopathy. Front Immunol. 2021;12:758375.","journal-title":"Front Immunol"},{"issue":"2","key":"1370_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00011-016-1002-6","volume":"66","author":"W Chen","year":"2017","unstructured":"Chen W, Zhao M, Zhao S, et al. Activation of the TXNIP\/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: A novel inhibitory effect of minocycline. Inflamm Res. 2017;66(2):157\u201366.","journal-title":"Inflamm Res"},{"key":"1370_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.707696","volume":"12","author":"Q Yu","year":"2021","unstructured":"Yu Q, Zhao T, Liu M, et al. Targeting NLRP3 inflammasome in translational treatment of nervous system diseases: An update. Front Pharmacol. 2021;12:707696.","journal-title":"Front Pharmacol"},{"issue":"Pt A","key":"1370_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115861","volume":"302","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wang J, Wang Y, et al. Pharmacological mechanism and clinical study of Qiming granules in treating diabetic retinopathy based on network pharmacology and literature review. J Ethnopharmacol. 2023;302(Pt A):115861.","journal-title":"J Ethnopharmacol"},{"key":"1370_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117935","volume":"256","author":"L Guan","year":"2020","unstructured":"Guan L, Li C, Zhang Y, et al. Puerarin ameliorates retinal ganglion cell damage induced by retinal ischemia\/reperfusion through inhibiting the activation of TLR4\/NLRP3 inflammasome. Life Sci. 2020;256:117935.","journal-title":"Life Sci"},{"key":"1370_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5070415","volume":"2020","author":"B Leng","year":"2020","unstructured":"Leng B, Li C, Sun Y, et al. Protective effect of astragaloside IV on high glucose-induced endothelial dysfunction via inhibition of P2X7R dependent P38 MAPK signaling pathway. Oxid Med Cell Longev. 2020;2020:5070415.","journal-title":"Oxid Med Cell Longev"},{"key":"1370_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9765119","volume":"2021","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhang X, Wang K, et al. An in vitro model of diabetic retinal vascular endothelial dysfunction and neuroretinal degeneration. J Diabetes Res. 2021;2021:9765119.","journal-title":"J Diabetes Res"},{"issue":"1","key":"1370_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-02040-8","volume":"18","author":"Y Li","year":"2021","unstructured":"Li Y, Song W, Tong Y, et al. Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a\/SYK\/NF-kappaB axis. J Neuroinflammation. 2021;18(1):1.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"1370_CR15","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.2337\/dc07-0332","volume":"30","author":"E Carrasco","year":"2007","unstructured":"Carrasco E, Hern\u00e1ndez C, Miralles A, et al. Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care. 2007;30(11):2902\u20138.","journal-title":"Diabetes Care"},{"issue":"12","key":"1370_CR16","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s00125-009-1548-8","volume":"52","author":"M Garcia-Ram\u00edrez","year":"2009","unstructured":"Garcia-Ram\u00edrez M, Hern\u00e1ndez C, Villarroel M, et al. Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy. Diabetologia. 2009;52(12):2633\u201341.","journal-title":"Diabetologia"},{"issue":"9","key":"1370_CR17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s00125-003-1177-6","volume":"46","author":"SH Park","year":"2003","unstructured":"Park SH, Park JW, Park SJ, et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia. 2003;46(9):1260\u20138.","journal-title":"Diabetologia"},{"issue":"11","key":"1370_CR18","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1167\/iovs.07-0427","volume":"48","author":"J Kusari","year":"2007","unstructured":"Kusari J, Zhou S, Padillo E, et al. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci. 2007;48(11):5152\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1370_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2337\/db18-0682","volume":"68","author":"R Simo","year":"2019","unstructured":"Simo R, Hernandez C, Porta M, et al. Effects of topically administered neuroprotective drugs in early stages of diabetic retinopathy: results of the EUROCONDOR Clinical Trial. Diabetes. 2019;68(2):457\u201363.","journal-title":"Diabetes"},{"issue":"12","key":"1370_CR20","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/cns.12150","volume":"19","author":"L Wang","year":"2013","unstructured":"Wang L, Deng QQ, Wu XH, et al. Upregulation of glutamate-aspartate transporter by glial cell line-derived neurotrophic factor ameliorates cell apoptosis in neural retina in streptozotocin-induced diabetic rats. CNS Neurosci Ther. 2013;19(12):945\u201353.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"1370_CR21","volume":"1","author":"Y Hejiang","year":"2011","unstructured":"Hejiang Y, Junguo D, Pengzheng L. Effects of Qiming granules on the polyol pathway in retinal tissues of experimental diabetic rats. J of Chin Ophthalmol and Otorhinolaryngol. 2011;1(1):3.","journal-title":"J of Chin Ophthalmol and Otorhinolaryngol"},{"key":"1370_CR22","unstructured":"Yijuan G. Clinical and experimental study on the intervention of Yiqi Yangxue Tongluo method in diabetic retinopathy [D]; China Academy of Chinese Medical Sciences, 2012."},{"issue":"2","key":"1370_CR23","first-page":"1","volume":"29","author":"D Junguo","year":"2006","unstructured":"Junguo D, Pingzheng L, Lie W, et al. Randomized Controlled Double-blind Multicentric Clinical Trial on Non-proliferative Diabetic Retinopathy Treated by Qiming Granules. J of Chengdu Univ of Tradit Chin Med. 2006;29(2):1\u20135.","journal-title":"J of Chengdu Univ of Tradit Chin Med"},{"issue":"1","key":"1370_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-019-0522-7","volume":"17","author":"R Zhang","year":"2019","unstructured":"Zhang R, Zhang X, Xing B, et al. Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice. Reprod Biol Endocrinol. 2019;17(1):77.","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"1370_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112207","volume":"9","author":"Y Ding","year":"2014","unstructured":"Ding Y, Yuan S, Liu X, et al. Protective effects of astragaloside IV on db\/db mice with diabetic retinopathy. PLoS ONE. 2014;9(11):e112207.","journal-title":"PLoS ONE"},{"key":"1370_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.abb.2017.06.006","volume":"627","author":"K Shruthi","year":"2017","unstructured":"Shruthi K, Reddy SS, Reddy GB. Ubiquitin-proteasome system and ER stress in the retina of diabetic rats. Arch Biochem Biophys. 2017;627:10\u201320.","journal-title":"Arch Biochem Biophys"},{"key":"1370_CR27","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8614.1","volume":"5","author":"T Pr\u00f3chnicki","year":"2016","unstructured":"Pr\u00f3chnicki T, Mangan MS, Latz E. Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation. F1000Res. 2016;5:F1000 Faculty Rev-469.","journal-title":"F1000Res"},{"issue":"3","key":"1370_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2337\/diabetes.47.3.445","volume":"47","author":"M Mizutani","year":"1998","unstructured":"Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes. 1998;47(3):445\u20139.","journal-title":"Diabetes"},{"issue":"5","key":"1370_CR29","volume":"4","author":"DJ Feenstra","year":"2013","unstructured":"Feenstra DJ, Yego EC, Mohr S. Modes of retinal cell death in diabetic retinopathy. J Clin Exp Ophthalmol. 2013;4(5):298.","journal-title":"J Clin Exp Ophthalmol"},{"key":"1370_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bcp.2017.12.021","volume":"151","author":"E Adinolfi","year":"2018","unstructured":"Adinolfi E, Giuliani AL, De Marchi E, et al. The P2X7 receptor: a main player in inflammation. Biochem Pharmacol. 2018;151:234\u201344.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"1370_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04786-w","volume":"13","author":"H Kong","year":"2022","unstructured":"Kong H, Zhao H, Chen T, et al. Targeted P2X7\/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy. Cell Death Dis. 2022;13(4):336.","journal-title":"Cell Death Dis"},{"key":"1370_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bcp.2019.07.010","volume":"168","author":"CBM Platania","year":"2019","unstructured":"Platania CBM, Lazzara F, Fidilio A, et al. Blood-retinal barrier protection against high glucose damage: the role of P2X7 receptor. Biochem Pharmacol. 2019;168:249\u201358.","journal-title":"Biochem Pharmacol"},{"key":"1370_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092101","author":"S Pavlou","year":"2019","unstructured":"Pavlou S, Augustine J, Cunning R, et al. Attenuating diabetic vascular and neuronal defects by targeting P2rx7. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20092101.","journal-title":"Int J Mol Sci"},{"key":"1370_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.exer.2016.10.005","volume":"153","author":"B Xue","year":"2016","unstructured":"Xue B, Xie Y, Xue Y, et al. Involvement of P2X(7) receptors in retinal ganglion cell apoptosis induced by activated Muller cells. Exp Eye Res. 2016;153:42\u201350.","journal-title":"Exp Eye Res"},{"key":"1370_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.662935","volume":"15","author":"A Oliveira-Giacomelli","year":"2021","unstructured":"Oliveira-Giacomelli A, Petiz LL, Andrejew R, et al. Role of P2X7 receptors in immune responses during neurodegeneration. Front Cell Neurosci. 2021;15:662935.","journal-title":"Front Cell Neurosci"},{"key":"1370_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.114942","volume":"198","author":"CBM Platania","year":"2022","unstructured":"Platania CBM, Drago F, Bucolo C. The P2X7 receptor as a new pharmacological target for retinal diseases. Biochem Pharmacol. 2022;198:114942.","journal-title":"Biochem Pharmacol"},{"key":"1370_CR37","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.2147\/DDDT.S152489","volume":"11","author":"Y Qiao","year":"2017","unstructured":"Qiao Y, Fan CL, Tang MK. Astragaloside IV protects rat retinal capillary endothelial cells against high glucose-induced oxidative injury. Drug Des Devel Ther. 2017;11:3567\u201377.","journal-title":"Drug Des Devel Ther"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01370-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:04:57Z","timestamp":1773698697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01370-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01370-8","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were approved by the Medical Ethics Committee of Chengdu University of Traditional Chinese Medicine (Grant Number: 2021-70).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}